Atlantic Equities raised the price target for Johnson & Johnson (NYSE: JNJ) from $167 to $170. Atlantic Equities analyst Steve Chesney maintained a Neutral rating. Johnson & Johnson shares rose 0.1% to $170.70 in pre-market trading.
Oppenheimer blames Matt Damon for failing to take a break from acting.During an interview Entertainment Weekly, Damon revealed that he promised his wife
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.